<DOC>
	<DOCNO>NCT00005764</DOCNO>
	<brief_summary>The purpose study see finding increase lactic acid abnormal fat distribution get good d4T replace abacavir , abacavir plus lamivudine , Combivir ( pill contain lamivudine plus zidovudine ) HIV-positive patient take anti-HIV therapy include stavudine ( d4T ) .</brief_summary>
	<brief_title>A Study Increased Lactic Acid Abnormal Fat Distribution HIV-Positive Patients</brief_title>
	<detailed_description>Patients allocate follow : ) zidovudine-naive patient switch Combivir d4t b ) zidovudine-experienced -intolerant patient switch abacavir d4t . Providers may choose Combivir abacavir switch d4t screen lactate level 2.2 mmol/L . Additionally , provider may choose switch maximum 2 drug , one must d4t , regimen . Each patient receive 48 week therapy . Visits make Weeks 2 , 4 , 8 , 12 , 16 , 20 , 24 , 32 , 40 , 48 . Tests , include biopsy , perform measure change body fat distribution change lactate level . Virologic immunologic outcome , change physical sign lipodystrophy , change self-reports health-related quality-of-life survey Body Image Questionnaire , change lipid profile marker metabolism , safety parameter evaluate also .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are least 18 year old . Agree intercourse 2 week , , 2 week study agree use effective method birth control . Have HIV1 RNA level less 400 copies/ml 2 recent measurement . Have least 1 follow situation : ( ) least 1 follow : ( 1 ) decrease facial fat , ( 2 ) decrease fat low limb , ( 3 ) decrease fat buttock area ; ( b ) increase lactate level great 2.2 mmol/L screen visit plus least 1 follow : ( 1 ) decrease facial fat , ( 2 ) decrease fat low limb , ( 3 ) decrease fat buttock area ; ( c ) increase lactate level great 2.2 mmol/L screen visit plus least 2 follow : ( 1 ) shortness breath , ( 2 ) weakness , ( 3 ) fast heartbeat , ( 4 ) recent weight loss ( 10 lb . within past 2 month ) , ( 5 ) pain and/or bloat abdomen , ( 6 ) nausea and/or vomit and/or lack appetite ; ( ) lactate level great 3.2 mmol/L screen visit . Are able read sixthgrade level . Have take d4T consistently 6 month enter study . Exclusion Criteria Patients eligible study : Have diabetes kidney failure . Have condition make unable participate study . Are unable take medication mouth . Have serious medical condition , congestive heart failure heart disease , would affect safety patient . Are take take abacavir plus Retrovir Combivir . Are pregnant breastfeeding . Are enrolled clinical study . Have reaction unable take abacavir take Retrovir past . Have take hydroxyurea within past 3 day plan take drug study . Have chemotherapy radiation therapy within 4 week prior screen visit ( except local treatment Kaposi 's sarcoma ) plan treatment study . Have take drug affect immune system , systemic corticosteroid , interleukin , vaccine , interferon , within 4 week prior screen visit . Have HIV vaccine within 3 month screen visit . Have take recombinant Human Growth Hormone ( rhGH ) , megestrol acetate , medicine contain oxandrolone , oxymetholone , nandrolone , DHEA , testosterone derivative , glucocorticoid systemic steroid ( except inhale topical steroid ) last 4 month plan take drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Zalcitabine</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Stavudine</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Blood</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Lipodystrophy</keyword>
	<keyword>Combivir</keyword>
	<keyword>Lactic Acid</keyword>
	<keyword>abacavir</keyword>
</DOC>